Alec D Keith

US Patent:

6805866, Oct 19, 2004

Filed:

Sep 23, 2002

Appl. No.:

10/252743

Inventors:

Alec D. Keith - Hilo HI
Kelly N. Gaisford - Baizman MT
Andrew H. Miller - San Francisco CA

Assignee:

Gaisford and Miller, Inc. - Burlingame CA

International Classification:

A61K 3584

US Classification:

42419515, 514885

Abstract:

An oral supplement composition and method of making and using it, in which a combination of fourteen different specialized mushroom species, each of which has its own unique immunomodulatory properties, demonstrate enhancement of the immune system. When taken together, the combination of mushroom species exert a potentiated, synergistic effect that enhances immune function greater than the sum of each mushroom species immunoenhancing influence. The oral supplement can be prepared into a variety of dosage forms, such as capsules, caplets, tablets, pills, dispersions, suspensions, solution, powders, teas, or syrup concentrates, and can be packaged in bottles or other packaging for sale.

US Patent:

7563460, Jul 21, 2009

Filed:

Feb 25, 2005

Appl. No.:

11/066621

Inventors:

Alec D. Keith - Hilo HI, US
William E. Crisp - Paradise Valley AZ, US

Assignee:

Med Five, Inc. - Honolulu HI

International Classification:

A61K 33/42
A61K 31/08

US Classification:

424606, 514723, 514 53, 514 57, 514312, 424 7838, 424601, 424692, 424738

Abstract:

A treatment protocol by which a renal stone patient is administered a chelating agent, generally once a day and preferably by mouth, during a treatment phase and is later administered the same chelating agent once a week, during a “maintenance” phase. The chelating agent is most preferably ethylene diamine tetraacetic acid (EDTA) and may be provided in a dosage form having an enteric coating and at least one external cathode and at least one external anode to create a galvanic current upon contact of the dosage form with the patient's intestinal contents.

US Patent:

20050271597, Dec 8, 2005

Filed:

Feb 11, 2005

Appl. No.:

11/057067

Inventors:

Alec Keith - Hilo HI, US

International Classification:

A61L009/04
A61K009/14
A61K031/57

US Classification:

424046000, 514177000

Abstract:

The present invention provides a method and composition for treatment of benign prostate hyperplasia (BPH) in men via a transscrotal delivery system. The composition of the present invention includes the steroid hormone progesterone containing permeation enhancers that greatly facilitate permeation through the skin, thus preventing modification of the constituents therein and providing continuous and sustained delivery of progesterone for several hours that mimics the circadian rhythm of endogenous progesterone. The progesterone composition preferably is capable of delivering an effective dosage amount of about 65-100 mg of progesterone per ml when applied directly onto the surface of scrotum.

US Patent:

20080153913, Jun 26, 2008

Filed:

Sep 15, 2004

Appl. No.:

10/571740

Inventors:

Ralph A. Cowden III - Zephyr Cove NV, US
Alec Keith - Hilo HI, US
James C. Roberts Jr. - Toledo OH, US
William E. Crisp - Paradise Valley AZ, US
Janey A. Lau - Kaneohe HI, US

Assignee:

Med Five, Inc. - Honolulu HI

International Classification:

A61K 31/685
A61K 38/46
A61K 31/195

US Classification:

514566, 42419515, 514440, 514474, 514 78, 424 946

Abstract:

Particular nutritional supplements and protocols emphasize the use of ethylenediamine tetraacetic acid as a mouth rinse, and as an enteric-coated oral pharmaceutical, further supplemented on a daily basis with both a combination of phosphatidyl lipids and alpha lipoic acid and a nutritional supplement containing approximately equal amounts of Reishi and Shiitake mushrooms.

US Patent:

43507077, Sep 21, 1982

Filed:

Feb 5, 1976

Appl. No.:

6/655413

Inventors:

Alec D. Keith - Boalsburg PA
Wallace Snipes - Pine Grove Mills PA

Assignee:

Research Corporation - New York NY

International Classification:

A61K 3105

US Classification:

424346

Abstract:

Inactivation of, and treatment of diseases caused by, lipid containing viruses, particularly herpes simplex virus, with butylated hydroxytoluene.

US Patent:

44709625, Sep 11, 1984

Filed:

Apr 28, 1981

Appl. No.:

6/258456

Inventors:

Alec D. Keith - State College PA
Wallace Snipes - State College PA

Assignee:

Key Pharmaceuticals, Inc. - Miami FL

International Classification:

A61L 1503
A61F 1300
A61K 970
A61K 4700

US Classification:

424 28

Abstract:

A polymeric diffusion matrix is provided comprising from about 2 to about 60% glycerol, from about 2 to about 15% polyvinylalcohol, from about 2 to about 10% water soluble polymer with hydration sites which in combination with the remaining ingredients yields a matrix capable of sustained release of a drug dispersed therein, and the balance water, the percentages being by weight.

US Patent:

52618706, Nov 16, 1993

Filed:

Feb 6, 1991

Appl. No.:

7/652295

Inventors:

Roy H. Hammerstedt - Boalsburg PA
Alec D. Keith - Boalsburg PA
Rupert P. Amann - Fort Collins CO

Assignee:

BioPore, Inc. - State College PA

International Classification:

A01N 102

US Classification:

600 35

Abstract:

A noningestible separation barrier having one or more pores or micropores (of one or more diameters) therein, with the pores or micropores being initially plugged with one or more materials selected for its/their solubility and/or integrity characteristics relative to certain environmental conditions. Ordinarily, the pores or micropores of the noningestible separation barrier are initially filled with at least one material having greater erodibility, under a given environmental condition, than the material constituting the separation barrier itself. The combination of the release rate (if any) or other membrane characteristic of the separation barrier, combined with the release rate and/or erosion life of the plugged pores, enables complex separations including variable release of cells, colloids, solutes or solvents over time, such as when the plugged pores remain intact until erosion is triggered by an environmental change such as solvent addition or ionic conditions or pH or thermal change Particular applications include specialized receptacles and protocols for the preservation of rooster sperm and turkey sperm for use in commercial artificial insemination applications.

US Patent:

51449579, Sep 8, 1992

Filed:

Apr 3, 1991

Appl. No.:

7/682394

Inventors:

Alec D. Keith - Boalsburg PA

Assignee:

Zetachron - State College PA

International Classification:

A61B 1500

US Classification:

128743

Abstract:

An allergic response indicator is provided which comprises a cutaneous three dimensional polymeric sheet capable of self-adherence to the epidermis of a subject and containing an indicator compound distributed throughout said cutaneous three dimensional polymeric sheet which, when applied to said epidermis, is released thereto over the period of application, whereby upon release of said indicator compound an allergic reaction is manifested by visual signs of skin irritation at the site of application upon the removal of said allergic response indicator.